Комплементарная и альтернативная терапия менопаузальных симптомов

1. Schoenaker D.A., Jackson C.A., Rowlands J.V., Mishra G.D. Socioeconomic position, lifestyle factors and age at natural menopause: a systematic review and meta-analyses of studies across six continents. Int. J. Epidemiol. 2014; 43(5): 1542-62.

2. Gold E.B., Crawford S.L., Avis N.E., Crandall C.J., Matthews K.A., Waetjen L.E. et al. Factors related to age at natural menopause: longitudinal analyses from SWAN. Am. J. Epidemiol. 2013; 178(1): 70-83.

3. Сметник В.П. Менопаузальная гормонотерапия и сохранение здоровья женщин зрелого возраста. Климактерий. 2014; 4: 8.

4. Deecher D.C., Dorries K. Understanding the pathophysiology of vasomotor symptoms (hot flushes and night sweats) that occur in perimenopause, menopause and postmenopause life stages. Arch. Womens Ment. Health. 2007; 10(6): 247-57.

5. Romanovsky A.A. Thermoregulation: some concepts have changed. Functional architecture of the thermoregulatory system. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2007; 292(1): R37-46.

6. Freedman R.R. Menopausal hot flashes: mechanisms, endocrinology, treatment. J. Steroid Biochem. Mol. Biol. 2014; 142: 115-20.

7. Freedman R.R., Wasson S. Miniature hygrometric hot flash recorder. Fertil. Steril. 2007; 88(2): 494-6.

8. Gerber L.M., Sievert L.L., Warren K., Pickering T.G., Schwartz J.E. Hot flushes are associated with increased ambulatory systolic blood pressure. Menopause. 2007; 14(2): 308-15.

9. Williams R.E., Kalilani L., DiBenedetti D.B., Zhou X., Granger A.L., Fehnel S.E. et al. Frequency and severity of vasomotor symptoms among peri- and postmenopasual women in the United States. Climacteric. 2008; 11(1): 32-43.

10. Freeman E.W., Sherif K. Prevalence of hot flushes and night sweats around the world: a systematic review. Climacteric. 2007; 10(3): 197-214.

11. Ziv-Gal A., Gallicchio L., Miller S.R., Zacur H.A., Jodi A., Flaws J.A. Genetic polymorphisms in the aryl hydrocarbon receptor signaling pathway as potential risk factors of menopausal hot flashes. Am. J. Obstet. Gynecol. 2012; 207(3): 202. e9-18.

12. Baber R.J., Panay N., Fenton A.; IMS Writing Group. Recommendations on women’s midlife health and menopause hormone therapy. Climacteric. 2016: 19(2): 109-50.

13. Cardini F., Lesi G., Lombardo F., van der Sluijs C.; MSCG – Menopause Survey Collaborative Group. The use of complementary and alternative medicine by women experiencing menopausal symptoms in Bologna. BMC Womens Health. 2010; 10: 7.

14. Feng Q., O’Malley B.W. Nuclear receptor modulation – role of coregulators in Selective Estrogen Receptor Modulator (SERM) actions. Steroids. 2014; 90: 39-43.

15. Martinkovich S., Shah D., Lobo Planey S., Arnott J.A. Selective estrogen receptor modulators: tissue specificity and clinical utility. Clin. Interv. Aging. 2014; 9: 1437-52.

16. Maximov Ph.Y., Lee T.M., Jordan V.C. The Discovery and development of Selective Estrogen Receptor Modulators (SERMs) for clinical practice. Curr. Clin. Pharmacol. 2013; 8(2): 135-55.

17. Henderson V.W., Ala T., Sainani K.L., Bernstein A.L., Stephenson B.S., Rosen A.C., Farlow M.R. Raloxifen for women with Alzheimer disease: A randomized controlled pilot trial. Neurology. 2015; 85(22): 1937-44.

18. Lethaby A., Marjoribanks J., Kronrnberg F., Roberts H., Eden J., Brown J. Phytoestrogens for menopausal vasomotor symptoms. Cochrane Database Syst. Rev. 2013; (12): CD001395.

19. Shakeri F., Taavoni S., Goushegir A., Haghani H. Effectiveness of red clover in alleviating menopausal symptoms: a 12-week randomized, controlled trial. Climacteric. 2015; 18(4): 568-73.

20. Cheng G., Wilczek B., Warner M., Gustafsson J.A., Landgren B.M. Isoflavone treatment for acute menopausal symptoms. Menopause. 2007; 14(3, Pt1):468-73.

21. D’Anna R., Cannata M.L., Atteritano M., Cancellieri F., Corrado F., Baviera G. et al. Effects of the phytoestrogen genistein on hot flushes, endometrium and vaginal epithelium in postmenopausal women: a 1-year randomized, double-blind, placebo-controlled study. Menopause. 2007; 14(4): 648-55.

22. Evans M., Elliott J.G., Sharma P., Berman R., Guthrie N. The effect of synthetic genistein on menopause symptom management in healthy postmenopausal women: a multi-center, randomized, placebo-controlled study. Maturitas. 2011; 68(2): 189-96.

23. Henderson V.W., St John J.A., Hodis H.N., Kono N., McCleary C.A., Franke A.A., Mack W.J.; WISH Research Group. Long-term soy isoflavone supplementation and cognition in women: A randomized, controlled trial. Neurology. 2012; 78(23): 1841-8.

24. Alkatib A.A., Cosma M., Elamin M.B., Erickson D., Swiglo B.A., Erwin P.J., Montori V.M. A systematic review and meta-analysis of randomized placebo-controlled trials of DHEA treatment effects on quality of life in women with adrenal insufficiency. J. Clin. Endocrinol. Metab. 2009; 94(10): 3676-81.

25. Davis S.R., Panjari M., Stanczyk F.Z. Dehydroepiandrosterone (DHEA) replacement for postmenopausal women. J. Clin. Endocrinol. Metab. 2011; 96(6): 1642-53.

26. Labrie F., Archer D., Bouchard C., Fortier M., Cusan L., Gomez J.L. et al. Effect of intravaginal dehydroepiandrostendione (Prasterone) on libido and sexual dysfunction in postmenopausal women. Menopause. 2009;16(5): 923-31.

27. Loprinzi C.L., Sloan J., Stearns V., Slack R., Iyengar M., Diekmann B. et al. Newer antidepressants and gabapentin for hot flashes: an individual patient pooled analysis. J. Clin. Oncol. 2009; 27(17): 2831-7.

28. Rada G., Capurro D., Pantoja T., Corbalán J., Moreno G., Letelier L.M., Vera C. Non-hormonal interventions for hot flashes in women with a history of breast cancer. Cochrane Database Syst. Rev. 2010; (9): CD004923.

29. Sideras K., Loprinzi C.L. Nonhormonal management of hot flashes for women on risk reduction therapy. J. Natl. Compr. Canc. Netw. 2010; 8(10): 1171-9.

30. Loprinzi C.L., Barton D.L., Sloan J.A., Novotny P.J., Dakhil S.R., Verdirame J.D. et al. Mayo Clinic and North Central Cancer Treatment Group hot flash studies: a 20-year experience. Menopause. 2008; 15(4, Pt1): 655-60.

31. Joffe H., Guthrie K.A., LaCroix A.Z., Reed S.D., Ensrud K.E., Manson J.E. et al. Low-dose estradiol and the serotonin-norepinephrine reuptake inhibitor venlafaxine for vasomotor symptoms: a randomized clinical trial. JAMA Intern. Med. 2014; 174(7): 1058-66.

32. Bordeleau L., Pritchard K.I., Loprinzi C.L., Ennis M., Jugovic O., Warr D. et al. Multicenter, randomized, cross-over clinical trial of venlafaxine versus gabapentin for the management of hot flashes in breast cancer survivors. J. Clin. Oncol. 2010; 28(35): 5147-52.

33. Albertazzi P. Non-estrogenic approaches for the treatment of climacteric symptoms. Climacteric. 2007; 10(Suppl. 2): 115-20.

34. Kelly C.M., Juurlink D.N., Gomes T., Duong-Hua M., Pritchard K.I., Austin P.C., Paszat L.F. Selective serotonin reuptake inhibitors and breast cancer mortality in women receiving tamoxifen: a population based cohort study. BMJ. 2010;340: c693.

35. Громова О.А., Торшин И.Ю., Лиманова О.А., Никонов А.А. Патофизиология вегетативно-сосудистых пароксизмов (приливы) у женщин в перод менопаузы и механизм действия бета-аланина. Новая клинико-фармакологическая концепция. Гинекология. 2010; 2: 29-36.

36. Liu Y.R., Jiang Y.L., Huang R.Q., Yang J.Y., Xiao B.K., Dong J.X. Hypericum perforatum L. preparations for menopause: a meta-analysis of efficacy and safety. Climacteric. 2014; 17(4): 325-35.

37. Beer A-M., Neff A. Differentiated evaluation of extract-specific evidence on cimicifuga racemosa’s efficacy and safety for climacteric complaints. Evid. Based Complement. Alternat. Med. 2013; 2013: Article ID 860602.

38. Czuczwar P., Paszkowski T., Lisiecki M., Woźniak S., Stępniak A. The safety and tolerance of phytotherapies in menopausal medicine – a review of the literature. Prz Menopauzalny. 2017; 16(1): 8-11.

39. Druckmann R. P123: Non-hormonal treatment of vasomotor symptoms in female patients with and after breast carcinoma. In: Abstracts for 15th World Congress on Menopause. Climacteric. 2016; 19(Suppl. 1): 84.

40. Joffe H., Massler A., Sharkey K.M. Evaluation and management of sleep disturbance during the menopause transition. Semin. Reprod. Med. 2010; 28(5): 404-21.

41. Joffe H., Petrillo L., Viguera A., Koukopoulos A., Silver-Heilman K., Farrell A. et al. Eszopiclone improves insomnia and depressive and anxious symptoms in perimenopausal and postmenopausal women with hot flashes: a randomized, double-blinded, placebo-controlled crossover trial. Am. J. Obstet. Gynecol. 2010; 202(2): 171, e1-71, e11.

42. Zick S.M., Wright B.D., Sen A., Arnedt J.T. Preliminary examination of the efficacy and safety of a standardized chamomile extract for chronic primary insomnia: A randomized placebo-controlled pilot study. BMC Complement. Altern. Med. 2011; 11: 78.

43. Boonmuen N., Gong P., Ali Z., Chittiboyina A.G., Khan I., Doerge D.R. et al. Licorice root components in dietary supplements are selective estrogen receptor modulators with a spectrum of estrogenic and anti-estrogenic activities. Steroids. 2016; 105: 42-9.

44. Yoo J.H., Liu Y., Kim H.S. Hawthorn fruit extract elevates expression of Nrf2/HO-1 and improves lipid profiles in ovariectomized rats. Nutrients. 2016; 8(5): 283.

45. Carpenter J.S., Burns D.S., Wu J., Otte J.L., Schneider B., Ryker K. et al. Paced respiration for vasomotor and other menopausal symptoms: a randomized, controlled trial. J. Gen. Intern. Med. 2013; 28(2): 193-200.

46. Norton S., Chilcot J., Hunter M.S. Cognitive-behavior therapy for menopausal symptoms (hot flushes and night sweats): moderators and mediators of treatment effects. Menopause. 2014; 21(6): 574-8.

47. Daley A., Stokes-Lampard H., Mutrie N., MacArthur C. Exercise for vasomotor symptoms. Cochrane Database Syst. Rev. 2007; (4): CD006108.

48. Chiu H.Y., Pan C.H., Shyu Y.K., Han B.C., Tsai P.S. Effects of acupuncture on menopause-related symptoms and quality of life in women in nature menopause: a meta-analysis of randomized controlled trials. Menopause. 2015; 22(2):234-44.

49. Elkins G.R., Fisher W.I., Johnson A.K., Carpenter J.S., Keith T.Z. Clinical hypnosis in the treatment of postmenopausal hot flashes: a randomized controlled trial. Menopause. 2013; 20(3): 291-8.

50. Walega D.R., Rubin D.H., Banuvar S., Shulman L.P., Maki P.M. Effects of stellate ganglion block on vasomotor symptoms: findings from a randomized controlled clinical trial in postmenopausal women. Menopause. 2014; 21(8): 807-14.

Поступила 08.09.2017

Принята в печать 22.09.2017